enrollment
-
Spine
Genesys Spine® Announces First Patients Enrolled in The SIros™ Lateral Sacroiliac Joint Fusion Study
AUSTIN, Texas, Oct. 21, 2022 /PRNewswire/ — Genesys Spine announced today the first two patients have been enrolled in the prospective SIros™ Lateral…
Read More » -
Sports Medicine
Ortho Regenerative Technologies Announces Enrollment of First Patient in its U.S. Phase l/ll Rotator Cuff Tear Repair Clinical Trial
First patient surgery completed; additional surgeries already scheduled8 clinical centres now fully initiated and recruiting / screening for patients MONTREAL, July…
Read More » -
Spine
Nexxt Spine Announces Early Significant Clinical Evidence Results and Completes Enrollment for NEXXT MATRIXX 3-D Printed Technologies
Noblesville, IN July 12, 2022 /OrthoSpineNews/ – Nexxt Spine, LLC a leader in design and development of 3D printed, porous,…
Read More » -
Spine
InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
Topline data expected to be reported in Q1 2023 June 2, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV),…
Read More » -
Spine
Karolinska Development’s portfolio company OssDsign completes patient enrollment to the TOP FUSION study
STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled…
Read More » -
Biologics
Cerapedics Completes Enrollment of Pivotal U.S. FDA IDE Study for its P-15L Bone Graft
The ASPIRE study is intended to evaluate the use of P-15L Bone Graft in transforaminal lumbar interbody fusion surgery in…
Read More » -
Spine
Synergy Disc® Announces Enrollment of First Patient in US IDE Clinical Trial
January 29, 2021 LOUISVILLE, Colo.–(BUSINESS WIRE)–Synergy Disc Replacement Ltd., a Colorado-based spinal medical device company and wholly owned subsidiary of…
Read More » -
Biologics
InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study
December 20, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient with a T8-9 fracture dislocation…
Read More » -
Financial
New Study to Evaluate Virtual Rehabilitation Platform for Physical Therapy after Total Knee Replacement Surgery
November 29, 2016 – SAN DIEGO–(BUSINESS WIRE)– Reflexion Health, Inc., a digital healthcare company, in conjunction with the Duke Clinical Research…
Read More » -
Recon
Orthofix Announces First Patient Enrollment in Osteoarthritis of the Knee Study
September 12, 2016 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V., (NASDAQ:OFIX), a diversified, global medical device company, today announced enrollment of the…
Read More » -
Hospitals
IlluminOss Medical Completes Enrollment for U.S. Clinical Trial Using Groundbreaking Photodynamic Bone Stabilization System
East Providence, RI (July 18, 2016) – IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive…
Read More » -
Recon
United Orthopedic Corporation Announces Enrollment of First U.S. Patient in Hip Replacement System Follow-Up Study
IRVINE, Calif., Feb. 23, 2016 /PRNewswire/ — United Orthopedic Corporation (UOC), a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments,…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the fifth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a fourth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Spine
Spinal Modulation closes enrollment in Axium chronic pain study
December 9, 2014 by Val Kennedy Spinal Modulation closes enrollment in a U.S. pivotal study of its Axium neurotransmitter system…
Read More »